Trials of AIDS vaccine to start in Switzerland and United KingdomBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7396.952/d (Published 03 May 2003) Cite this as: BMJ 2003;326:952
- Fiona Fleck
Clinical trials of a new vaccine against HIV, which has infected more than 40 million people worldwide, start in Switzerland and the United Kingdom in June.
Dr Jean-Pierre Kraehenbuhl, vice president of EuroVacc, the foundation organising the trials, said two vaccines would be tested: DNA-C, developed by Professor Hans Wolf of the University of Regensburg, Germany, and its booster, NYVAC, developed by the French pharmaceutical company Aventis.
Dr Kraehenbuhl said that about 160 healthy volunteers—half in London and half in the Swiss city of Lausanne, where EuroVacc is based—will test the vaccine …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial